Nu Skin Enterprises, Inc. (NYSE: NUS) spotted trading -43.85% off 52-week high price. On the other end, the stock has been noted 11.88% away from the low price over the last 52-weeks. The stock changed -0.66% to recent value of $39.19. The stock transacted 445602 shares during most recent day however it has an average volume of 380.88K shares. The company has 55.92M of outstanding shares and 54.07M shares were floated in the market.
Nu Skin Enterprises, Inc. (NUS) recently reported third-quarter 2019 results.
“We delivered strong profitability, with earnings per share at the high end of our range Because of our focus on operational efficiencies,” stated Ritch Wood, chief executive officer. “Revenue came in slightly below expectation, primarily Because of the challenging regulatory environment in Mainland China, where meeting restrictions continued throughout the quarter. Despite this, our sequential sales leader trends stabilized both in China and globally, and recent product introductions and business incentives drove year-over-year increases in consumer acquisition. Our manufacturing section also continued to perform well, with revenue growing 18 percent this quarter.”
Mark Lawrence, chief financial officer, added, “Our fourth quarter revenue guidance is $570 to $590M, which includes an approximate 2 percent unfavorable foreign currency impact, and earnings per share outlook is for $0.68 to $0.75, considering expenses related to LIVE. For the full year, we project revenue of $2.41 to $2.43B, with an approximate 4 percent negative foreign currency impact and earnings per share of $3.07 to $3.14.”
Its earnings per share (EPS) expected to touch remained -33.20% for this year while earning per share for the next 5-years is expected to reach at -0.92%. NUS have a gross margin of 76.10% and an operating margin of 9.20% while its profit margin remained 4.60% for the last 12 months. According to the most recent quarter its current ratio was 2 that represents company’s ability to meet its current financial obligations. The price moved ahead of 2.20% from the mean of 20 days, -4.12% from mean of 50 days SMA and performed -14.19% from mean of 200 days price. Company’s performance for the week was 3.46%, -0.15% for month and YTD performance remained -36.10%.